#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia Neurofibromatosis Ependymoma Burkitt's lymphoma refractory Polycythaemia vera Hereditary spastic paraplegia Von Willebrand's disease Guillain-Barre syndrome Turner's syndrome Meningitis meningococcal Krabbe's disease Thrombotic thrombocytopenic purpura Metachromatic leukodystrophy Pulmonary sarcoidosis Bronchiectasis More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma – Treatment Sjogren’s syndrome – Diagnostics Mucopolysaccharidosis I – Basic Information Haemophilia – Diagnostics Netherton’s syndrome – Basic Information Factor IX deficiency – Trials in Disease Metachromatic leukodystrophy – Basic Information Synovial sarcoma metastatic – Diagnostics Methylmalonic acidaemia Biotinidase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efzofitimod Silibinin Almagate Nemtabrutinib CHONDROITIN SULFATE SODIUM Fludrocortisone Gsk4381562A TEV-53408 Vgl101 Vincristine Lenacapavir Sodium Birtamimab AZD0292 Flortaucipir (18F) Sodium Fluoride (18F) Crizanlizumab Loratadine Gremubamab OMECAMTIV MECARBIL Dimeticone More therapies…

    Learn about Your Condition

    Restless legs syndrome Cardiac valve disease Chronic hepatic failure Affective disorder Ulcerative keratitis Metabolic disorder Deafness traumatic Febrile neutropenia Atrophic vulvovaginitis Invasive breast carcinoma Torticollis Toxic epidermal necrolysis Hyperchylomicronaemia Oxygen therapy Enteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • 1-{4-[2-(5-Ethoxymethyl-2-Methyl-Phenylamino)-Oxazol-5-Yl]-Phenyl}-Imidazolidin-2-One
    • Azacitidine
    • Venetoclax
    France Germany Greece Spain

  • Study of acetylsalicylic acid and clopidogrel treatment after left atrial appendage closure in patients with atrial fibrillation and chronic kidney disease

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Poland

  • Study of Levosimendan Before Tricuspid Valve Surgery in Patients with Right Ventricular Dysfunction

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Coronary artery bypass
    Investigated Drugs:
    • Levosimendan
    France

  • Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Mitral valve incompetence
    • Atrial fibrillation
    Investigated Drugs:
    • Heparin Sodium
    Poland

  • Study of Durvalumab Combined with Chemotherapy (Gemcitabine/Cisplatin or Gemcitabine/Carboplatin) for Patients with High-Risk Upper Urinary Tract Cancer Before Surgery

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France

  • Study of rituximab and glucocorticoids versus placebo and glucocorticoids in adults with newly diagnosed or relapsing IgA vasculitis

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Henoch-Schonlein purpura
    Investigated Drugs:
    • Rituximab
    France
Previous Page
1 … 843 844 845 846 847 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!